Literature DB >> 15761612

NFAT transcription factors: from cell cycle to tumor development.

J P B Viola1, L D S Carvalho, B P F Fonseca, L K Teixeira.   

Abstract

The nuclear factor of activated T cells (NFAT) family of transcription factors has been primarily identified in immune cells; however, these proteins have been recently found to be functionally active in several other non-immune cell types. NFAT proteins are activated upon different stimuli that lead to increased intracellular calcium levels. Regardless of their widely known cytokine gene expression properties, NFATs have been shown to regulate other genes related to cell cycle progression, cell differentiation and apoptosis, revealing a broader role for these proteins in normal cell physiology. Several reports have addressed the participation of NFATs in many aspects of malignant cell transformation and tumorigenic processes. In this review, we will discuss the involvement of the different NFAT family members in the regulation of cell cycling, differentiation and tumor formation, and also its implications on oncogenesis. Better understanding the mechanisms by which NFATs regulate cell cycle and tumor-related events should be relevant for the development of rational anti-cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761612     DOI: 10.1590/s0100-879x2005000300003

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  33 in total

Review 1.  Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Authors:  Anouchka Skoudy; Inmaculada Hernández-Muñoz; Pilar Navarro
Journal:  J Gastrointest Cancer       Date:  2011-06

2.  NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.

Authors:  Leonardo K Teixeira; Nina Carrossini; Cristiane Sécca; José E Kroll; Déborah C DaCunha; Douglas V Faget; Lilian D S Carvalho; Sandro J de Souza; João P B Viola
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

3.  Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Authors:  Malte Buchholz; Alexandra Schatz; Martin Wagner; Patrick Michl; Thomas Linhart; Guido Adler; Thomas M Gress; Volker Ellenrieder
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

4.  NFAT4 deficiency results in incomplete liver regeneration following partial hepatectomy.

Authors:  Ketsia B Pierre; Christopher M Jones; Janene M Pierce; Ian B Nicoud; T Mark Earl; Ravi S Chari
Journal:  J Surg Res       Date:  2008-08-27       Impact factor: 2.192

5.  Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors.

Authors:  Bruno K Robbs; Andre L S Cruz; Miriam B F Werneck; Giuliana P Mognol; João P B Viola
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

6.  mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.

Authors:  Venus Zafari; Shahryar Hashemzadeh; Mohammadali Hosseinpour Feizi; Nasser Pouladi; Leila Rostami Zadeh; Ebrahim Sakhinia
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

7.  Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity.

Authors:  Alison C Macleod; Lillian R Klug; Janice Patterson; Diana J Griffith; Carol Beadling; Ajia Town; Michael C Heinrich
Journal:  Mol Cancer Ther       Date:  2014-09-24       Impact factor: 6.261

8.  NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Authors:  Pedro I Lucena; Douglas V Faget; Emilia Pachulec; Marcela C Robaina; Claudete E Klumb; Bruno K Robbs; João P B Viola
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

9.  Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

Authors:  Sreelatha Gopinath; Sravan K Vanamala; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  Cell Mol Life Sci       Date:  2009-09-27       Impact factor: 9.261

10.  Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.

Authors:  Askar Akimzhanov; Laszlo Krenacs; Timm Schlegel; Stefan Klein-Hessling; Enikö Bagdi; Eva Stelkovics; Eisaku Kondo; Sergei Chuvpilo; Philipp Wilke; Andris Avots; Stefan Gattenlöhner; Hans-Konrad Müller-Hermelink; Alois Palmetshofer; Edgar Serfling
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.